BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lai CY, Scarr E, Udawela M, Everall I, Chen WJ, Dean B. Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics. World J Psychiatr 2016; 6(1): 102-117 [PMID: 27014601 DOI: 10.5498/wjp.v6.i1.102]
URL: https://www.wjgnet.com/1007-9327/full/v6/i1/102.htm
Number Citing Articles
1
Michael D.E. Sewell, Lorena Jiménez-Sánchez, Xueyi Shen, Amelia J. Edmondson-Stait, Claire Green, Mark J. Adams, Olivia M. Rifai, Andrew M. McIntosh, Donald M. Lyall, Heather C. Whalley, Stephen M. Lawrie. Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobankBrain, Behavior, and Immunity 2021; 97: 32 doi: 10.1016/j.bbi.2021.06.002
2
Elizabeth Ruiz-Sánchez, Janet Jiménez-Genchi, Yessica M. Alcántara-Flores, Carlos J. Castañeda-González, Carlos L. Aviña-Cervantes, Petra Yescas, María del Socorro González-Valadez, Nancy Martínez-Rodríguez, Antonio Ríos-Ortiz, Martha González-González, María E. López-Navarro, Patricia Rojas. Working memory deficits in schizophrenia are associated with the rs34884856 variant and expression levels of the NR4A2 gene in a sample Mexican population: a case control studyBMC Psychiatry 2021; 21(1) doi: 10.1186/s12888-021-03081-w
3
Esmaeil Shahsavand Ananloo. Psychotic Disorders - An Update2018;  doi: 10.5772/intechopen.75930
4
H Jiang, S Chen, C Li, N Lu, Y Yue, Y Yin, Y Zhang, X Zhi, D Zhang, Y Yuan. The serum protein levels of the tPA–BDNF pathway are implicated in depression and antidepressant treatmentTranslational Psychiatry 2017; 7(4): e1079 doi: 10.1038/tp.2017.43
5
Chuanjun Zhuo, Gongying Li, Xiaodong Lin, Deguo Jiang, Yong Xu, Hongjun Tian, Wenqiang Wang, Xueqin Song. Strategies to solve the reverse inference fallacy in future MRI studies of schizophrenia: a reviewBrain Imaging and Behavior 2021; 15(2): 1115 doi: 10.1007/s11682-020-00284-9
6
C.M. Loureiro, R. Shuhama, H.A. Fachim, P.R. Menezes, C.M. Del-Ben, P. Louzada-Junior. Low plasma concentrations of N-methyl-d-aspartate receptor subunits as a possible biomarker for psychosisSchizophrenia Research 2018; 202: 55 doi: 10.1016/j.schres.2018.06.037
7
Rudolf Engelke, Sami Ouanes, Suhaila Ghuloum, Rifka Chamali, Nancy Kiwan, Hina Sarwath, Frank Schmidt, Karsten Suhre, Hassen Al-Amin. Proteomic Analysis of Plasma Markers in Patients Maintained on Antipsychotics: Comparison to Patients Off Antipsychotics and Normal ControlsFrontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.809071
8
Charalampos T Kazakos, Vasilios Karageorgiou. Retinal Changes in Schizophrenia: A Systematic Review and Meta-analysis Based on Individual Participant DataSchizophrenia Bulletin 2019;  doi: 10.1093/schbul/sbz106
9
Jiajun Yin, Yana Lu, Shui Yu, Zhanzhan Dai, Fuquan Zhang, Jianmin Yuan. Exploring the mRNA expression level of RELN in peripheral blood of schizophrenia patients before and after antipsychotic treatmentHereditas 2020; 157(1) doi: 10.1186/s41065-020-00158-6
10
Jairo Vinícius Pinto, Ives Cavalcante Passos, Fernando Gomes, Ramiro Reckziegel, Flavio Kapczinski, Benson Mwangi, Márcia Kauer-Sant'Anna. Peripheral biomarker signatures of bipolar disorder and schizophrenia: A machine learning approachSchizophrenia Research 2017; 188: 182 doi: 10.1016/j.schres.2017.01.018
11
Junfang Chen, Emanuel Schwarz. The role of blood-based biomarkers in advancing personalized therapy of schizophreniaExpert Review of Precision Medicine and Drug Development 2017; 2(6): 363 doi: 10.1080/23808993.2017.1400906
12
A. V. Yakimets, S. A. Zozulya, I. V. Oleichik, T. P. Klyushnik. Dynamics of clinical and biological indices of the asthenic symptom-complex during immunotropic therapy of patients with schizophreniaZhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2018; 118(3): 70 doi: 10.17116/jnevro20181183170-76
13
Javier Gilabert-Juan, Guillermo López-Campos, Noelia Sebastiá-Ortega, Sonia Guara-Ciurana, Fulgencio Ruso-Julve, Carlos Prieto, Benedicto Crespo-Facorro, Julio Sanjuán, María Dolores Moltó. Time dependent expression of the blood biomarkers EIF2D and TOX in patients with schizophreniaBrain, Behavior, and Immunity 2019; 80: 909 doi: 10.1016/j.bbi.2019.05.015
14
M. N. Grunina, A. M. Zabotina, M. M. Pchelina, R. F. Nasyrova, D. N. Sosin, E. E. Ershov, A. E. Taraskina, E. M. Krupitskiy. Mononuclear Cells of Peripheral Blood in vitro. A Model of Antipsychotic Therapy PersonalizationCell and Tissue Biology 2019; 13(1): 64 doi: 10.1134/S1990519X1901005X
15
Kosuke Kajitani, Kazuyuki Yanagimoto, Yusaku Nakabeppu. Serum galectin-3, but not galectin-1, levels are elevated in schizophrenia: implications for the role of inflammationPsychopharmacology 2017; 234(19): 2919 doi: 10.1007/s00213-017-4683-9
16
Zhe Lu, Tianyang Wen, Yingtan Wang, Weijing Kan, Guanglei Xun. Peripheral non-enzymatic antioxidants in patients with schizophrenia: a case-control studyBMC Psychiatry 2020; 20(1) doi: 10.1186/s12888-020-02635-8
17
Satyajit Mohite, Fang Yang, Pooja A. Amin, Giovana Zunta-Soares, Gabriela D. Colpo, Laura Stertz, Ajaykumar N. Sharma, Gabriel R. Fries, Consuelo Walss-Bass, Jair C. Soares, Olaoluwa O. Okusaga, Xiang Yang Zhang. Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controlsPLOS ONE 2017; 12(3): e0174073 doi: 10.1371/journal.pone.0174073
18
Jennifer Davison, Aoife O'Gorman, Lorraine Brennan, David R. Cotter. A systematic review of metabolite biomarkers of schizophreniaSchizophrenia Research 2018; 195: 32 doi: 10.1016/j.schres.2017.09.021
19
Fei Ye, Qiongqiong Zhan, Wenhuan Xiao, Weiwei Sha, Xiaobin Zhang. Altered serum levels of glial cell line‐derived neurotrophic factor in male chronic schizophrenia patients with tardive dyskinesiaInternational Journal of Methods in Psychiatric Research 2018; 27(4) doi: 10.1002/mpr.1727
20
Cynthia H. Lee, Duncan Sinclair, Maryanne O'Donnell, Cherrie Galletly, Dennis Liu, Cynthia Shannon Weickert, Thomas W. Weickert. Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorderSchizophrenia Research 2019; 213: 87 doi: 10.1016/j.schres.2019.06.026
21
Boris Chaumette, Oussama Kebir, Juliette Pouch, Bertrand Ducos, Fekrije Selimi, Raphael Gaillard, Marie-Odile Krebs. Longitudinal Analyses of Blood Transcriptome During Conversion to PsychosisSchizophrenia Bulletin 2019; 45(1): 247 doi: 10.1093/schbul/sby009
22
Hyerim Kim, Xudong Wang, Peng Jin. Developing DNA methylation-based diagnostic biomarkersJournal of Genetics and Genomics 2018; 45(2): 87 doi: 10.1016/j.jgg.2018.02.003
23
Chuanjun Zhuo, Yudong Yao, Yong Xu, Chuanxin Liu, Min Chen, Feng Ji, Jie Li, Hongjun Tian, Deguo Jiang, Chongguang Lin, Ce Chen. Schizophrenia and gut-flora related epigenetic factorsProgress in Neuro-Psychopharmacology and Biological Psychiatry 2019; 90: 49 doi: 10.1016/j.pnpbp.2018.11.005
24
Ladislav Hosák. Biomarkers of schizophrenia - a brief review and the recent knowledgePsychiatrie pro praxi 2016; 17(2): 44 doi: 10.36290/psy.2016.012
25
Jingyu Liu, Jiayu Chen, Nora Perrone-Bizzozero, Vince D. Calhoun. A Perspective of the Cross-Tissue Interplay of Genetics, Epigenetics, and Transcriptomics, and Their Relation to Brain Based Phenotypes in SchizophreniaFrontiers in Genetics 2018; 9 doi: 10.3389/fgene.2018.00343
26
M. N. Grunina, A. M. Zabotina, A. S. Zhuravlev, M. M. Pchelina, E. V. Volkova, R. F. Nasyrova, A. E. Taraskina, E. M. Krupitsky. DOPAMINE RECEPTOR D2 (DRD2) IN PERIPHERAL BLOOD LYMPHOCYTES AS BIOMARKER OF RESPONSE TO ANTIPSYCHOTIC MEDICATIONThe Scientific Notes of the Pavlov University 2020; 27(1): 45 doi: 10.24884/1607-4181-2020-27-1-45-56
27
William R. Reay, Dylan J. Kiltschewskij, Michael P. Geaghan, Joshua R. Atkins, Vaughan J. Carr, Melissa J. Green, Murray J. Cairns. Genetic estimates of correlation and causality between blood-based biomarkers and psychiatric disordersScience Advances 2022; 8(14) doi: 10.1126/sciadv.abj8969
28
E.S. Ershova, E.M. Jestkova, I.V. Chestkov, L.N. Porokhovnik, V.L. Izevskaya, S.I. Kutsev, N.N. Veiko, G. Shmarina, O. Dolgikh, S.V. Kostyuk. Quantification of cell-free DNA in blood plasma and DNA damage degree in lymphocytes to evaluate dysregulation of apoptosis in schizophrenia patientsJournal of Psychiatric Research 2017; 87: 15 doi: 10.1016/j.jpsychires.2016.12.006
29
Berko Milleit, Jana Hesse, Kerstin Langbein, Kristin Rödiger, Christine Milleit, Ute C. Meier, Peter Elsner, Uta-Christina Hipler, Stefan Smesny. Pronounced immunological abnormalities in unmedicated first episode as compared to chronic schizophrenia patientsNeurology, Psychiatry and Brain Research 2019; 34: 58 doi: 10.1016/j.npbr.2019.10.002
30
Benjamín Rodríguez, João Victor Nani, Priscila G.C. Almeida, Elisa Brietzke, Richard S. Lee, Mirian A.F. Hayashi. Neuropeptides and oligopeptidases in schizophreniaNeuroscience & Biobehavioral Reviews 2020; 108: 679 doi: 10.1016/j.neubiorev.2019.11.024
31
Hani Sabaie, Madiheh Mazaheri Moghaddam, Marziyeh Mazaheri Moghaddam, Noora Karim Ahangar, Mohammad Reza Asadi, Bashdar Mahmud Hussen, Mohammad Taheri, Maryam Rezazadeh. Bioinformatics analysis of long non-coding RNA-associated competing endogenous RNA network in schizophreniaScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-03993-3
32
Davin Lee, Jinsoo Seo, Hae chan Jeong, Hyosang Lee, Sung Bae Lee. The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived NeuronsFrontiers in Molecular Neuroscience 2021; 14 doi: 10.3389/fnmol.2021.756613
33
Jiahui Ma, Lailai Yan, Tongjun Guo, Siyu Yang, Dawei Ni, Yaqiong Liu, Jingyu Wang. A pilot study of biomarkers of oxidative stress in serum and schizophreniaPsychiatry Research 2020; 284: 112757 doi: 10.1016/j.psychres.2020.112757
34
Andrea Schmitt, Daniel Martins-de-Souza, Schahram Akbarian, Juliana S. Cassoli, Hannelore Ehrenreich, Andre Fischer, Alfred Fonteh, Wagner F. Gattaz, Michael Gawlik, Manfred Gerlach, Edna Grünblatt, Tobias Halene, Alkomiet Hasan, Kenij Hashimoto, Yong-Ku Kim, Sophie-Kathrin Kirchner, Johannes Kornhuber, Theo F.J. Kraus, Berend Malchow, Juliana M. Nascimento, Moritz Rossner, Markus Schwarz, Johann Steiner, Leda Talib, Florence Thibaut, Peter Riederer, Peter Falkai. Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanismsThe World Journal of Biological Psychiatry 2017; 18(5): 330 doi: 10.1080/15622975.2016.1224929
35
James R. Mansfield, Paul C. Guest, Jared Burks. Proteomic Methods in Neuropsychiatric ResearchAdvances in Experimental Medicine and Biology 2017; 974: 327 doi: 10.1007/978-3-319-52479-5_32
36
Daniela Rodrigues-Amorim, Tania Rivera-Baltanás, María del Carmen Vallejo-Curto, Cynthia Rodriguez-Jamardo, Elena de las Heras, Carolina Barreiro-Villar, María Blanco-Formoso, Patricia Fernández-Palleiro, María Álvarez-Ariza, Marta López, Alejandro García-Caballero, José Manuel Olivares, Carlos Spuch. Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune PathwaysFrontiers in Psychiatry 2019; 10 doi: 10.3389/fpsyt.2019.00885
37
Eunkyoung Kim, Jinyang Li, Mijeong Kang, Deanna L. Kelly, Shuo Chen, Alessandra Napolitano, Lucia Panzella, Xiaowen Shi, Kun Yan, Si Wu, Jana Shen, William E. Bentley, Gregory F. Payne. Redox Is a Global Biodevice Information Processing ModalityProceedings of the IEEE 2019; 107(7): 1402 doi: 10.1109/JPROC.2019.2908582
38
S Liu, F Zhang, Y Y Shugart, L Yang, X Li, Z Liu, N Sun, C Yang, X Guo, J Shi, L Wang, L Cheng, K Zhang, T Yang, Y Xu. The early growth response protein 1-miR-30a-5p-neurogenic differentiation factor 1 axis as a novel biomarker for schizophrenia diagnosis and treatment monitoringTranslational Psychiatry 2017; 7(1): e998 doi: 10.1038/tp.2016.268
39
Kamil Jonak, Arkadiusz Syta, Hanna Karakuła-Juchnowicz, Paweł Krukow. The Clinical Application of EEG-Signals Recurrence Analysis as a Measure of Functional Connectivity: Comparative Case Study of Patients with Various Neuropsychiatric DisordersBrain Sciences 2020; 10(6): 380 doi: 10.3390/brainsci10060380
40
Noriaki Yahata, Kiyoto Kasai, Mitsuo Kawato. Computational neuroscience approach to biomarkers and treatments for mental disordersPsychiatry and Clinical Neurosciences 2017; 71(4): 215 doi: 10.1111/pcn.12502
41
Matea Perkovic, Gordana Erjavec, Dubravka Strac, Suzana Uzun, Oliver Kozumplik, Nela Pivac. Theranostic Biomarkers for SchizophreniaInternational Journal of Molecular Sciences 2017; 18(4): 733 doi: 10.3390/ijms18040733
42
Xingbing Huang, Xiong Huang, Yanling Zhou, Hongbo He, Fang Mei, Bin Sun, Jair C. Soares, Xiang Yang Zhang. Association of serum BDNF levels with psychotic symptom in chronic patients with treatment-resistant depression in a Chinese Han populationPsychiatry Research 2017; 257: 279 doi: 10.1016/j.psychres.2017.07.076
43
Kärt Kriisa, Liisa Leppik, Roman Balõtšev, Aigar Ottas, Ursel Soomets, Kati Koido, Vallo Volke, Jürgen Innos, Liina Haring, Eero Vasar, Mihkel Zilmer. Profiling of Acylcarnitines in First Episode Psychosis before and after Antipsychotic TreatmentJournal of Proteome Research 2017; 16(10): 3558 doi: 10.1021/acs.jproteome.7b00279
44
Weichen Song, Lihua Xu, Tianhong Zhang, Weidi Wang, Yingmei Fu, Qingqing Xu, Ruixue Yuan, Ailing Ning, Jijun Wang, Guan Ning Lin, Shunying Yu. Peripheral transcriptome of clinical high‐risk psychosis reflects symptom alteration and helps prognosis predictionPsychiatry and Clinical Neurosciences 2022; 76(6): 268 doi: 10.1111/pcn.13346
45
Elizaveta S. Ershova, Oksana N. Agafonova, Natalia V. Zakharova, Lidia V. Bravve, Elizaveta M. Jestkova, Vera E. Golimbet, Tatiana V. Lezheiko, Anna Y. Morozova, Andrey V. Martynov, Roman V. Veiko, Pavel E. Umriukhin, Georgiy P. Kostyuk, Sergey I. Kutsev, Natalia N. Veiko, Svetlana V. Kostyuk. Copy Number Variation of Satellite III (1q12) in Patients With SchizophreniaFrontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.01132
46
Mohammad Reza Safari, Alireza Komaki, Shahram Arsang-Jang, Mohammad Taheri, Soudeh Ghafouri-Fard. Expression Pattern of Long Non-coding RNAs in Schizophrenic PatientsCellular and Molecular Neurobiology 2019; 39(2): 211 doi: 10.1007/s10571-018-0640-3
47
Hamid Fallah, Iman Azari, Seyedeh Morvarid Neishabouri, Vahid Kholghi Oskooei, Mohammad Taheri, Soudeh Ghafouri-Fard. Sex-specific up-regulation of lncRNAs in peripheral blood of patients with schizophreniaScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49265-z
48
Mitsuyuki Matsumoto, Noah M. Walton, Hiroshi Yamada, Yuji Kondo, Gerard J. Marek, Katsunori Tajinda. The impact of genetics on future drug discovery in schizophreniaExpert Opinion on Drug Discovery 2017; 12(7): 673 doi: 10.1080/17460441.2017.1324419
49
Xiaowei Tang, Chao Zhou, Ju Gao, Weiwei Duan, Miao Yu, Wenhuan Xiao, Xiaobin Zhang, Hui Dong, Xiang Wang, Xiangrong Zhang. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunctionBMC Psychiatry 2019; 19(1) doi: 10.1186/s12888-019-2231-3
50
Suzhen Chen, Haitang Jiang, Yang Liu, Zhenhua Hou, Yingying Yue, Yuqun Zhang, Fuying Zhao, Zhi Xu, Yinghui Li, Xiaodong Mou, Lei Li, Tianyu Wang, Jingjing Zhao, Chongyang Han, Yuxiu Sui, Ming Wang, Zhong Yang, Yan Lu, Yifeng Zhu, Jianhua Li, Xinhua Shen, Fei Sun, Qingsong Chen, Huanxin Chen, Yonggui Yuan. Combined serum levels of multiple proteins in tPA-BDNF pathway may aid the diagnosis of five mental disordersScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-06832-6
51
Michal Ordak, Malgorzata Libman-Sokolowska, Tadeusz Nasierowski, Bogna Badyra, Leszek Kaczmarek, Elzbieta Muszynska, Magdalena Bujalska-Zadrozny. Matrix metalloproteinase-3 serum levels in schizophrenic patientsInternational Journal of Psychiatry in Clinical Practice 2022; : 1 doi: 10.1080/13651501.2022.2057332
52
Else Eising, Nadine Pelzer, Lisanne S. Vijfhuizen, Boukje de Vries, Michel D. Ferrari, Peter A. C. ‘t Hoen, Gisela M. Terwindt, Arn M. J. M. van den Maagdenberg. Identifying a gene expression signature of cluster headache in bloodScientific Reports 2017; 7(1) doi: 10.1038/srep40218
53
Dag K. Solberg, Helge Refsum, Ole A. Andreassen, Håvard Bentsen. A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophreniaActa Neuropsychiatrica 2019; 31(04): 202 doi: 10.1017/neu.2019.14
54
Eunkyoung Kim, Zoe Keskey, Mijeong Kang, Christopher Kitchen, William E. Bentley, Shuo Chen, Deanna L. Kelly, Gregory F. Payne. Validation of oxidative stress assay for schizophreniaSchizophrenia Research 2019; 212: 126 doi: 10.1016/j.schres.2019.07.057
55
Konstantinos N. Fountoulakis, Panagiotis Panagiotidis, Thomas Tegos, Vasileios Kimiskidis, Ioannis Nimatoudis. Paternal age and specific neurological soft signs as reliable and valid neurobiological markers for the diagnosis of patients with schizophreniaEuropean Archives of Psychiatry and Clinical Neuroscience 2021;  doi: 10.1007/s00406-021-01357-6
56
Clément Dondé, Marine Mondino, Jérôme Brunelin, Frédéric Haesebaert. Sensory-targeted cognitive training for schizophreniaExpert Review of Neurotherapeutics 2019; 19(3): 211 doi: 10.1080/14737175.2019.1581609
57
A. E. Taraskina, R. F. Nasyrova, A. M. Zabotina, D. N. Sosin, К. А. Sosina, E. E. Ershov, M. N. Grunina, E. M. Krupitsky. Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic aminesBMC Psychiatry 2017; 17(1) doi: 10.1186/s12888-017-1562-1
58
Eriko Tani, Tohru Ohnuma, Hitoki Hirose, Ken Nakayama, Wanyi Mao, Mariko Nakadaira, Narihiro Orimo, Hiroki Yamashita, Yuto Takebayashi, Yasue Miki, Narimasa Katsuta, Shohei Nishimon, Toshio Hasegawa, Etsuko Komiyama, Yasushi Suga, Shigaku Ikeda, Heii Arai. Skin advanced glycation end products as biomarkers of photosensitivity in schizophreniaInternational Journal of Methods in Psychiatric Research 2019; 28(1): e1769 doi: 10.1002/mpr.1769
59
Sanghyeon Kim, Yousang Jo, Maree J. Webster, Doheon Lee. Shared co-expression networks in frontal cortex of the normal aged brain and schizophreniaSchizophrenia Research 2019; 204: 253 doi: 10.1016/j.schres.2018.09.010
60
Zhijun Li, Xinwei Li, Mengdi Jin, Yang Liu, Yang He, Ningning Jia, Xingyao Cui, Yane Liu, Guoyan Hu, Qiong Yu. Identification of potential blood biomarkers for early diagnosis of schizophrenia through RNA sequencing analysisJournal of Psychiatric Research 2022; 147: 39 doi: 10.1016/j.jpsychires.2022.01.003
61
Chao Li, Zhenchun Shi, Jiacui Ji, Gengyun Niu, Zengxun Liu. Associations of C-Reactive Protein, Free Triiodothyronine, Thyroid Stimulating Hormone and Creatinine Levels with Agitation in Patients with Schizophrenia: A Comparative Cross-Sectional StudyNeuropsychiatric Disease and Treatment 2021; : 2575 doi: 10.2147/NDT.S322005
62
Daniela Rodrigues-Amorim, Tania Rivera-Baltanás, Marta López, Carlos Spuch, Jose M. Olivares, Roberto C. Agís-Balboa. Schizophrenia: A review of potential biomarkersJournal of Psychiatric Research 2017; 93: 37 doi: 10.1016/j.jpsychires.2017.05.009
63
Vjekoslav Peitl, Biserka Getaldić-Švarc, Dalibor Karlović. Platelet Serotonin Concentration Is Associated with Illness Duration in Schizophrenia and Chronological Age in DepressionPsychiatry Investigation 2020; 17(6): 579 doi: 10.30773/pi.2020.0033
64
Manabu Makinodan, Keiko Iwata, Daisuke Ikawa, Yasunori Yamashita, Kazuhiko Yamamuro, Michihiro Toritsuka, Sohei Kimoto, Kazuki Okumura, Takahira Yamauchi, Hiroki Yoshino, Masatsugu Tsujii, Toshiro Sugiyama, Kenji Tsuchiya, Norio Mori, Hideo Matsuzaki, Toshifumi Kishimoto. Tumor necrosis factor-alpha expression in peripheral blood mononuclear cells correlates with early childhood social interaction in autism spectrum disorderNeurochemistry International 2017; 104: 1 doi: 10.1016/j.neuint.2016.12.005
65
Maria N. Grunina, Mariia A. Belinskaia, Alexander S. Zhuravlev, Regina F. Nasyrova, Evgeny M. Krupitsky, Anastasiya E. Taraskina, Anna M. Zabotina. Aberrant alternative splicing of HTR2A exon II in peripheral blood lymphocytes of drug-naïve schizophrenic patientsHeliyon 2020; 6(12): e05809 doi: 10.1016/j.heliyon.2020.e05809
66
Phatcharee Chukaew, Nutthaya Bunmak, Natchaphon Auampradit, Apinya Siripaiboonkij, Witchuda Saengsawang, Woraphat Ratta‐apha. Correlation of BDNF , VEGF , TNF ‐α, and S100B with cognitive impairments in chronic, medicated schizophrenia patients Neuropsychopharmacology Reports 2022;  doi: 10.1002/npr2.12261
67
Marie Arsalidou, Zachary Yaple, Tomas Jurcik, Vadim Ushakov. Cognitive Brain Signatures of Youth With Early Onset and Relatives With Schizophrenia: Evidence From fMRI Meta-analysesSchizophrenia Bulletin 2020; 46(4): 857 doi: 10.1093/schbul/sbz130
68
Brian Dean. The Neuroscience of Depression2021; : 89 doi: 10.1016/B978-0-12-817935-2.00037-4
69
Kurumi Taniguchi, Haruka Sawamura, Yuka Ikeda, Ai Tsuji, Yasuko Kitagishi, Satoru Matsuda. D-Amino Acids as a Biomarker in SchizophreniaDiseases 2022; 10(1): 9 doi: 10.3390/diseases10010009
70
Anastasia Levchenko, Timur Nurgaliev, Alexander Kanapin, Anastasia Samsonova, Raul R. Gainetdinov. Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disordersHeliyon 2020; 6(5): e03990 doi: 10.1016/j.heliyon.2020.e03990
71
Jobbe Goossens, Manuel Morrens, Violette Coppens. The Potential Use of Peripheral Blood Mononuclear Cells as Biomarkers for Treatment Response and Outcome Prediction in Psychiatry: A Systematic ReviewMolecular Diagnosis & Therapy 2021; 25(3): 283 doi: 10.1007/s40291-021-00516-8
72
Matej Ľupták, Danica Michaličková, Zdeněk Fišar, Eva Kitzlerová, Jana Hroudová. Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targetsWorld Journal of Psychiatry 2021; 11(7): 277-296 doi: 10.5498/wjp.v11.i7.277
73
Elior Rahmani, Regev Schweiger, Liat Shenhav, Theodora Wingert, Ira Hofer, Eilon Gabel, Eleazar Eskin, Eran Halperin. BayesCCE: a Bayesian framework for estimating cell-type composition from DNA methylation without the need for methylation referenceGenome Biology 2018; 19(1) doi: 10.1186/s13059-018-1513-2
74
Jiao Jia, Xiaofei Liu, Lina Ma, Yong Xu, Yan Ren. A preliminary analysis of LncRNA biomarkers for schizophreniaEpigenomics 2021; 13(18): 1443 doi: 10.2217/epi-2021-0223
75
Thomas A Pollak, Jonathan P Rogers, Robert G Nagele, Mark Peakman, James M Stone, Anthony S David, Philip McGuire. Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic DisordersSchizophrenia Bulletin 2019; 45(1): 233 doi: 10.1093/schbul/sby021
76
Kiri T. Granger, Anahita Talwar, Jennifer H. Barnett. Latent inhibition and its potential as a biomarker for schizophreniaBiomarkers in Neuropsychiatry 2020; 3: 100025 doi: 10.1016/j.bionps.2020.100025
77
Dariusz Juchnowicz, Michał Dzikowski, Joanna Rog, Napoleon Waszkiewicz, Kaja Hanna Karakuła, Anna Zalewska, Mateusz Maciejczyk, Hanna Karakula-Juchnowicz. Pro/Antioxidant State as a Potential Biomarker of SchizophreniaJournal of Clinical Medicine 2021; 10(18): 4156 doi: 10.3390/jcm10184156
78
Sha Liu, Fuquan Zhang, Xijin Wang, Yin Yao Shugart, Yingying Zhao, Xinrong Li, Zhifen Liu, Ning Sun, Chunxia Yang, Kerang Zhang, Weihua Yue, Xin Yu, Yong Xu. Diagnostic value of blood-derived microRNAs for schizophrenia: results of a meta-analysis and validationScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-15751-5
79
Sofia Ramos Ferreira, Diana Moura, Pedro Oliveira, Vítor Santos, Miguel Bajouco, Sofia Morais, Manuel Coroa, Bruno Manadas, Nuno Madeira. Metabolic parameters as possible diagnostic predictors in first‐episode psychosis: An exploratory retrospective cohort studyEarly Intervention in Psychiatry 2021;  doi: 10.1111/eip.13257
80
Lawrence Rook. Biomarkers of mental illness and the human hand: A systematic reviewThe European Journal of Psychiatry 2022; 36(2): 77 doi: 10.1016/j.ejpsy.2022.01.007
81
Zongchang Li, Ying He, Hongying Han, Yao Zhou, Xiaoqian Ma, Dong Wang, Jun Zhou, Honghong Ren, Liu Yuan, Jinsong Tang, Xiaofen Zong, Maolin Hu, Xiaogang Chen. COMT, 5-HTR2A, and SLC6A4 mRNA Expressions in First-Episode Antipsychotic-Naïve Schizophrenia and Association With Treatment OutcomesFrontiers in Psychiatry 2018; 9 doi: 10.3389/fpsyt.2018.00577
82
Marina Sergeevna Konkova, Elizaveta Sergeevna Ershova, Ekaterina Alekseevna Savinova, Elena Mikhailovna Malinovskaya, Galina Vasilievna Shmarina, Andrey Vladimirovich Martynov, Roman Vladimirovich Veiko, Nataly Vyacheslavovna Zakharova, Pavel Umriukhin, Georgy Petrovich Kostyuk, Vera Leonidovna Izhevskaya, Sergey Ivanovich Kutsev, Natalia Nikolaevna Veiko, Svetlana Victorovna Kostyuk. 1Q12 Loci Movement in the Interphase Nucleus Under the Action of ROS Is an Important Component of the Mechanism That Determines Copy Number Variation of Satellite III (1q12) in Health and SchizophreniaFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00386
83
Diğdem Göverti, Rabia Nazik Yüksel, Hasan Kaya, Nihan Büyüklüoğlu, Çiğdem Yücel, Erol Göka. Serum concentrations of aminoacylase 1 in schizophrenia as a potential biomarker: a case-sibling-control studyNordic Journal of Psychiatry 2022; 76(5): 380 doi: 10.1080/08039488.2021.1981435
84
I. V. Chestkov, E. M. Jestkova, E. S. Ershova, V. G. Golimbet, T. V. Lezheiko, N. Yu Kolesina, O. A. Dolgikh, V. L. Izhevskaya, G. P. Kostyuk, S. I. Kutsev, N. N. Veiko, S. V. Kostyuk. ROS-Induced DNA Damage Associates with Abundance of Mitochondrial DNA in White Blood Cells of the Untreated Schizophrenic PatientsOxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/8587475
85
Ting Cao, NaNa Li, HuaLin Cai. Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist?Schizophrenia Research 2020; 226: 95 doi: 10.1016/j.schres.2019.03.009
86
Eunkyoung Kim, Zhiling Zhao, John Robertson Rzasa, Matthew Glassman, William E. Bentley, Shuo Chen, Deanna L. Kelly, Gregory F. Payne. Association of acute psychosocial stress with oxidative stress: Evidence from serum analysisRedox Biology 2021; 47: 102138 doi: 10.1016/j.redox.2021.102138